Puma Biotechnology
- Market cap
- 506.39M
- P/E (TTM)i
- 19.24
- P/Bi
- 3.65
- EPSi
- 0.61
- Div yieldi
- 0.00%
- 52W posi
- 95%
Anonymous reader poll. Unscientific, not investment advice.
Puma Biotechnology shares were changing hands at 9.81, up 3.26% on the day. Its market capitalisation is about 506.39M, the #3745 most valuable US-listed company we track. Over the past year the stock has ranged from 4.58 to 10.10; it now sits 95% up that band.
✦ StockVane Quant Insights how this is computed
- Recent price momentum is +56.3% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 8.4% of float.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 9.50
- Open
- 9.45
- Day range
- 9.41 - 9.96
- Avg price
- 9.81
- Volume
- 375.31K
- Turnover
- 3.68M
- Turnover ratei
- 0.95%
- Volume ratioi
- 0.94
- Amplitudei
- 5.79%
- 52-week rangei
- 4.58 - 10.10
Valuation
- P/Ei
- 16.08
- P/E (TTM)i
- 19.24
- P/Bi
- 3.65
- EPSi
- 0.61
- Book value / shi
- 2.68
- Net profit
- 31.49M
- Net assets
- 138.55M
Share structure
- Market cap
- 506.39M
- Float capi
- 388.88M
- Shares out
- 51.62M
- Float sharesi
- 39.64M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- --
2.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-1.92M net over the window
Short interest
- Shares short
- 4.32M
- % of floati
- 8.37%
- Days to coveri
- 13.80
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Puma Biotechnology (PBYI)?
Puma Biotechnology last traded at 9.81. The quote on this page refreshes every few seconds while US markets are open.
What is Puma Biotechnology's market cap?
About 506.39M.
What is the P/E ratio of Puma Biotechnology?
The trailing twelve-month P/E is 19.24. The Valuation tab shows it against the stock's own five-year range.
Does Puma Biotechnology pay a dividend?
Puma Biotechnology does not currently pay a regular dividend.
Quote time 2026-10-08 09:07:53 · For reference only, not investment advice and not tailored to your situation.